Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Vesalius Therapeutics and GSK form strategic alliance for neurodegenerative disease treatments

Nov 16, 2024•over 1 year ago

Contract Type

partnership

BiotechnologyTherapeuticsPharmaceutical

Description

Vesalius Therapeutics and GSK have announced a strategic partnership aimed at discovering and developing therapeutics for Parkinson's disease and other neurodegenerative diseases. The agreement includes the identification of novel intervention points and potential milestone payments of up to $570 million, along with tiered royalties.

Company Information

Company

Vesalius Therapeutics and GSK

About

Vesalius Therapeutics is a biotech firm specializing in the discovery and development of therapeutics for neurodegenerative diseases. GSK is a multinational pharmaceutical company.

Predictive Intelligence
Strategic

ML-powered predictions for Vesalius Therapeutics and GSK's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.